Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 129 a 148 di 186
Titolo Data di pubblicazione Autore(i) File
PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in NAFLD. 2015 Musso G; Cassader M; Gambino R
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with Nonalcoholic Fatty Liver Disease 2009 L. Valenti; E. Galmozzi; P. Dongiovanni; R. Rametta; E. Lattuada; M. Zappa; E. Mozzi; G. Roviaro; M. Maggioni; E. Vanni; E. Bugianesi; A. L. Fracanzani; S. Fargion
Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? 2007 GAMBINO R; CASSADER M; PAGANO G; DURAZZO M; MUSSO G
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 1997 POLLICINO T ;ZANETTI AR ;CACCIOLA I ;PETIT MA ;SMEDILE A ;CAMPO S ;SAGLIOCCA L ;PASQUALI M ;TANZI E ;LONGO G ;RAIMONDO G
Prediction of Early Graft Loss after Liver Transplantation based on Donor-Recipient Matching 2013 Angelico, Mario; Nardi, Alessandra; Romagnoli, Renato; Marianelli, Tania; Corradini Ginanni, Stefano; Strazzabosco, Mario
"Prevalence of diabetes mellitus immunologic marker in patients with chronic hepatitis C before and after interferon therapy" 1997 Durazzo M;Mariani M.G;Biava MA;Clerico A;D'Errico N;Sacchi C;Tabone M;Saracco G;Rizzetto M;Pagano G.
Prognostic significance of diabetes in patients with cirrhosis. 1994 BIANCHI G ;MARCHESINI G ;ZOLI M ;BUGIANESI E ;FABBRI A ;PISI E
PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients 2013 Heiner Wedemeyer;Donald Jensen;Robert Herring;Peter Ferenci;Mang-Ming Ma;Stefan Zeuzem;Maribel Rodriguez-Torres;Natalie Bzowej;Paul Pockros;John Vierling;David Ipe;Marie Lou Munson;Ya-Chi Chen;Isabel Najera;James Thommes; Alessia Ciancio; (in Collaborators)
The protective action of the berberine in murine and rat models of steatohepatitis is associated with reduced inflammasome activation 2012 Elisa Vivoli; Stefano Milani; Angela Provenzano; Stefania Madiai; Erica Novo; Claudia P. Oliveira; Gloriano Moneti; Maurizio Parola; Fabio Marra
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors. 1994 GIANNELLI G ;SAVOIA P ;SCHIRALDI O ;LOSPALLUTI M ;DE LUCA M ;MARCHISIO PC ;QUARANTA V
qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis 2019 Liu, Feng; Goh, George Boon-Bee; Tiniakos, Dina; Wee, Aileen; Leow, Wei-Qiang; Zhao, Jing-Min; Rao, Hui-Ying; Wang, Xiao-Xiao; Wang, Qin; Wan, Wei-Keat; Lim, Kiat-Hon; Romero-Gomez, Manuel; Petta, Salvatore; Bugianesi, Elisabetta; Tan, Chee-Kiat; Harrison, Stephen A; Anstee, Quentin M; Jason Chang, Pik-Eu; Wei, Lai
Receptors of calcium and calcimimetic agents inside the cirrotic liver are new targets to reduce portal pressure. 2010 Sansoè G;Aragno M; Tommasinelli C.E; Parola M.
Recombinant interferon-alfa therapy in children with chronic hepatitis C. 1995 Bortolotti F; Giacchino R; Vajro P; Barbera C; Crivellaro C; Alberti A; Nebbia G; Zancan L; De Moliner L; Bertolini A
Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. 1994 Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Reduced liver injury is associated with diminished oxidative stress in monocyte chemoattractan protein-1(MCP-1)-deficient mice 2004 Parola M; Aleffi S; Petrai I; Aragno M; Mastrocola R; Zamara E; Novo E; Delogu W; DeFranco R; Pinzani M; Rollins BJ; Marra F.
Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins. 1999 CHIARPOTTO E; DOMENICOTTI C; PAOLA D; VITALI A; NITTI M; PRONZATO MA; BIASI F; COTTALASSO D; MARINARI UM; DRAGONETTI A; CESARO P; ISIDORO C; POLI G
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver 2004 Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Release of hepatocyte-derived microparticles dueing lipotoxicity induces angiogenesis. 2011 Povero D; Berk MP; Mulya A; Thapaliya S; Parola M; Feldstein AE.
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression in patients with NAFLD 2016 Pelusi, Serena; Petta, Salvatore; Rosso, Chiara; Borroni, Vittorio; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Craxi, Antonio; Bugianesi, Elisabetta; Fargion, Silvia; Valenti, Luca
Reperfusion damage to the bile canaliculi in transplanted human liver. 1996 CUTRIN JC; CANTINO D; BIASI F; CHIARPOTTO E; SALIZZONI M; ANDORNO E; MASSANO G; LANFRANCO G; RIZZETTO M; BOVERIS A; POLI G
Mostrati risultati da 129 a 148 di 186
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile